Discounted Cash Flow (DCF) Analysis Levered

MiMedx Group, Inc. (MDXG)

$2.74

-0.10 (-3.52%)
All numbers are in Millions, Currency in USD
Stock DCF: 0.17 | 2.74 | overvalue

Free Cash Flow

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 321.14359.11299.25248.23258.61247.16236.22225.76215.76206.21
Revenue (%)
Operating Cash Flow 62.9435.80-39.41-30.26-1.981.701.621.551.481.42
Operating Cash Flow (%)
Capital Expenditure -5.40-10.03-2.22-4.55-3.47-4.15-3.96-3.79-3.62-3.46
Capital Expenditure (%)
Free Cash Flow 57.5425.77-41.63-34.82-5.45-2.45-2.34-2.24-2.14-2.04

Weighted Average Cost Of Capital

Share price $ 2.74
Beta 1.751
Diluted Shares Outstanding 108.26
Cost of Debt
Tax Rate -2.46
After-tax Cost of Debt 10.35%
Risk-Free Rate
Market Risk Premium
Cost of Equity 11.964
Total Debt 48.13
Total Equity 296.62
Total Capital 344.75
Debt Weighting 13.96
Equity Weighting 86.04
Wacc

Build Up Free Cash Flow

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 321.14359.11299.25248.23258.61247.16236.22225.76215.76206.21
Operating Cash Flow 62.9435.80-39.41-30.26-1.981.701.621.551.481.42
Capital Expenditure -5.40-10.03-2.22-4.55-3.47-4.15-3.96-3.79-3.62-3.46
Free Cash Flow 57.5425.77-41.63-34.82-5.45-2.45-2.34-2.24-2.14-2.04
WACC
PV LFCF -2.19-1.87-1.60-1.37-1.17
SUM PV LFCF -8.21

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 11.74
Free cash flow (t + 1) -2.08
Terminal Value -21.39
Present Value of Terminal Value -12.28

Intrinsic Value

Enterprise Value -20.49
Net Debt -38.96
Equity Value 18.47
Shares Outstanding 108.26
Equity Value Per Share 0.17